Both Dexcom Stelo and Abbott Lingo are FDA-cleared OTC continuous glucose monitors marketed at the same audience — adults without diabetes who want to understand how food, sleep, and stress move their blood sugar. They cost almost the same per month. They use similar underlying CGM technology. The marketing makes them sound interchangeable.
They’re not. There are three specific differences that decide which one is right for any given buyer, and missing any of them leads to a $50-90 sensor stuck on the back of your arm that doesn’t work the way you need it to. This is the decision tree, the spec comparison, and the two factors the manufacturer pages don’t tell you.
Health note: Stelo and Lingo are wellness biosensors cleared by the FDA for adults 18 and older without diabetes. Neither device has low-glucose alarms, neither is intended for diabetes management, and neither is appropriate for users who take insulin. If you have diabetes or suspect you do, talk to your doctor about a prescription CGM like the Dexcom G7 or FreeStyle Libre 3, not an OTC wellness device.
The Three Questions That Decide
Almost every “Stelo vs Lingo” comparison spends 2,000 words on app screenshots and ends with “they’re both great, depends on your needs.” This is the version that actually picks one. Three questions, asked in order, give you the answer.
Question 1: Do you use an iPhone or an Android phone?
This is the most decisive question and the one almost no comparison leads with. The Abbott Lingo app is available on the Apple App Store only. If you’re on Android, your only option of the two is Dexcom Stelo, whose app runs on both iOS and Android.
This isn’t a minor compatibility note. The CGM is useless without the app — the sensor itself just transmits Bluetooth data, all the readings, trends, charts, and notifications live in the phone app. An Android user buying Lingo is buying a $49 paperweight.
If you’re on Android: Stelo. Stop here. The other two questions don’t apply to you.
If you’re on iPhone: continue to Question 2.
Question 2: Do you want food-by-food coaching, or just glucose patterns?
This is where the philosophies of the two devices diverge. Stelo’s app is deliberately minimalist — it shows your glucose curve, your trends over time, and basic spike detection. There is no food logging, no meal scoring, no AI coaching. You see the data and decide what to do with it.
Lingo’s app is built around a feature called the Lingo Count. Every time you eat something, you log it (or let the app’s pattern-recognition guess), and the app gives that meal a 1-10 score based on the glucose response it triggered. Over time, the Lingo Count nudges you toward foods that produce smaller glucose excursions. It’s structured behavior change, not just data display.
The right choice here is personality-driven, not technical:
Choose Lingo if you want the app to actively guide your decisions — show you which of your usual breakfasts is the worst offender, score your meal choices, and gamify the feedback loop. People who like Noom-style coaching apps tend to like Lingo’s approach.
Choose Stelo if you want the raw glucose data and you’ll do the interpretation yourself. People who already track sleep, nutrition, or training in spreadsheets and want one more data feed tend to prefer Stelo’s hands-off design.
Question 3: Do you wear an Oura Ring (or plan to)?
This is the question that breaks ties for biohacker-stack users. Stelo has native integration with the Oura Ring — your glucose data flows directly into the Oura app alongside sleep, heart rate variability, body temperature, and readiness scores. You can see “my glucose spiked at 11 PM the same night my deep sleep was 30% below baseline” in one chart, in one app, without manual cross-referencing.
Lingo has no Oura integration. If you have an Oura Ring, want one, or use Apple Health as your aggregator (Oura also syncs to Apple Health), Stelo is the better-integrated choice. Lingo lives in its own walled garden.
For everyone else, this question doesn’t decide anything — both apps work fine standalone.
The Decision Tree, Visualized
Pulling those three questions together produces the actual logic flow:
| If you… | Buy |
|---|---|
| Use Android (any model) | Stelo — Lingo doesn’t have an Android app |
| Use iPhone AND want active food coaching | Lingo — for the Lingo Count meal-scoring system |
| Use iPhone AND already use Oura Ring (or want to) | Stelo — native Oura integration |
| Use iPhone AND want minimalist data-only display | Stelo — cleaner app, fewer features |
| Use iPhone AND want maximum features per dollar | Lingo — more app features at slightly lower cost |
| Use iPhone AND need provider data sharing (clinician access) | Stelo — only OTC CGM with built-in provider sharing |
The Full Spec Comparison
For users who want to verify the decision against the underlying technical specs:
| Spec | Dexcom Stelo | Abbott Lingo |
|---|---|---|
| FDA clearance date | March 5, 2024 (first OTC CGM) | May 29, 2024 |
| Cleared for | Adults 18+ without diabetes | Adults 18+ without diabetes |
| Sensor wear time | 15 days | 14 days |
| Sensor warmup | ~30 minutes | ~60 minutes |
| MARD (accuracy) | ~8.3% | ~9.3% |
| Glucose readings | Sensor reads every minute; app displays continuously | Sensor reads every minute; app displays continuously |
| Waterproof rating | Submersible to 8 ft for up to 24 hours | Water-resistant for showers/swimming |
| App platforms | iOS + Android | iOS only |
| High-glucose alerts | Yes — Spike Detection + user-set threshold (default 250 mg/dL) | Limited — alerts on patterns, not real-time thresholds |
| Low-glucose alarms | No | No |
| Apple Watch support | Yes | Yes (with Lingo app installed on iPhone) |
| Oura Ring integration | Native | None |
| Apple Health integration | Yes | Yes |
| Google Health Connect | Yes | No (no Android app) |
| Provider data sharing | Yes (only OTC CGM with this feature) | No |
| Single sensor price | $89 / 2-pack (≈ $44.50 per sensor) | $49 for one sensor |
| Subscription pricing | ~$89/month | ~$84/month (12-week pack: $249 = $20.75/week) |
Two Things the Spec Sheet Won’t Tell You
The technical comparison above misses two factors that meaningfully affect day-to-day use. Both came out repeatedly in user reviews and hands-on comparison testing by independent publishers like CNN Underscored, Not Just a Patch, and Plotline Health.
1. The first-week recalibration period is real for both, but Lingo is worse
Both devices read interstitial fluid (the fluid between cells under the skin), not blood directly. Both need a few days of wear before their readings stabilize and align with what a fingerstick blood meter would show. Independent comparisons consistently find Lingo’s first 24-48 hours read substantially differently from later in the wear period — sometimes by 20-40 mg/dL, which is enough to make breakfast on Day 1 look like a glucose disaster when it’s just sensor calibration noise.
Stelo also has a calibration period but it’s milder and shorter — most users see stable readings within 12-18 hours after the 30-minute warmup. If you’re going to obsessively check your first day’s data (most people do, despite advice not to), Stelo will produce less misleading numbers than Lingo during that window.
2. The food-pattern recognition in Lingo is generic, not personalized
The Lingo Count is marketed as personalized coaching, but the underlying scoring is based on Abbott’s general algorithm — not your individual metabolic responses. If a meal triggers a 50 mg/dL spike for you and a 25 mg/dL spike for the next user, you’ll both get scored on the absolute spike, not on a personalized baseline. Users who already understand glucose response tend to find the scoring useful as confirmation; users new to the concept sometimes find it confusingly punitive for foods that are actually fine for their personal metabolism.
Stelo’s lack of a scoring system is, paradoxically, a feature for users who would rather draw their own conclusions from the curve than be told what to think about each meal.
12-Month Cost Comparison
If you use either device continuously for a year (every sensor replaced as the prior one expires):
| Usage pattern | Stelo | Lingo |
|---|---|---|
| Continuous (subscription) | ~$1,068/year | ~$1,008/year |
| Quarterly experiments (4 sensors/year, ~8 weeks of data) | ~$180/year | ~$196/year |
| One-month diagnostic (2 sensors) | ~$89 | ~$98 |
For continuous wear, Lingo is about $60/year cheaper. For diagnostic use (the use case most non-diabetic adults actually want), the cost difference is negligible — under $20 either way.
The Honest Recommendation by Use Case
You’re a biohacker with an Oura Ring or Whoop band → Stelo. The Oura integration is the differentiator and you’ll get more value from the data flowing into one app than from Lingo’s standalone scoring.
You’re new to glucose tracking and want the app to teach you → Lingo (if iPhone). The Lingo Count system is the best onboarding experience in this category for users who don’t already know what to look for in a glucose curve.
You want to run a 4-week food-response experiment and then stop → either, but pick based on phone OS. Stelo if you’ll repeat the experiment quarterly because the data is more shareable with a clinician.
You’re on Android → Stelo. There’s no other option.
You’re considering this for someone over 65 → Stelo, primarily for the cleaner app design (Lingo’s gamification can feel overwhelming) and the provider sharing if you want a clinician to review the data.
You take insulin or have diagnosed diabetes → Neither. Get a prescription Dexcom G7 or FreeStyle Libre 3 through your endocrinologist. The OTC products explicitly don’t have the low-glucose alarms that make a real CGM safe for insulin users.
What Both Devices Won’t Do
This is the section worth reading even if you’ve already decided. Both Stelo and Lingo share four limitations that buyers regularly underestimate:
No low-glucose alerts. Both devices will tell you when glucose is high. Neither will warn you when it goes low. This is by FDA-clearance design — they’re wellness devices, not medical alarms — but it matters if you sometimes go below 70 mg/dL (a sign of reactive hypoglycemia worth investigating with your doctor, not a CGM).
Not for pediatric use. Both are cleared for adults 18+ only. Off-label pediatric use voids the FDA clearance and any reasonable safety claim.
Not for pregnancy. Glucose physiology in pregnancy is materially different from non-pregnant baseline. Neither device is validated for pregnancy use and the readings can be misleading.
Insurance won’t cover them. Because they’re wellness-positioned rather than medical-need-positioned, neither HSA nor FSA coverage is reliable, and traditional insurance won’t reimburse. You’re paying out of pocket.
If You Want the Full Product Comparison
The above is the decision tree for picking between Stelo and Lingo specifically. If you also want to consider the cash-pay FreeStyle Libre 3 Plus (a third option, technically a prescription CGM that’s available OTC at higher cost with better accuracy and real-time low-glucose alerts), see our full Best CGM for Non-Diabetics 2026 guide. The Libre 3 Plus is the right answer for users who want the accuracy and alerting capabilities of a medical-grade CGM and are willing to pay roughly 50% more per sensor for them.
Sources and Methodology
Spec data verified against manufacturer pages at stelo.com and hellolingo.com, FDA 510(k) clearance database, and independent hands-on testing reported by CNN Underscored (2026 head-to-head review), Not Just a Patch’s CGM comparison, and Plotline Health’s 2026 OTC CGM guide. MARD figures sourced from each manufacturer’s FDA submission summary; user-experience observations on first-week calibration drift and Lingo Count subjective scoring drawn from the independent comparison reviews above and aggregated Amazon review patterns. As an Amazon Associate, DeskFitPro earns from qualifying purchases through links on the related guide pages.
Last updated: June 26, 2026. Pricing verified against Stelo.com and HelloLingo.com on the publication date.